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THE	  EFFECTS	  OF	  EXERCISE	  PRECONDITIONING	  ON	  FOCAL	  ISCHEMIC	  STROKE	  
	  
	  
	   Cleaved	   fragments	   of	   the	   extracellular	   matrix	   protein	   perlecan	   have	   been	   shown	   to	  
promote	  neuroprotection	  and	  repair	  after	   ischemic	  stroke.	  The	  cysteine	  proteases	  cathepsin	  B	  
and	   L	   as	   well	   as	   the	   metalloprotease	   bone	   morphogenic	   protein	   1	   (BMP-­‐1)	   are	   capable	   of	  
releasing	   the	   biologically	   active	   C-­‐terminal	   laminin-­‐like	   globular	   domain	   (LG3)	   of	   perlecan.	  
Exercise,	  a	  known	  method	  of	  reducing	  stroke	  risk	  and	  severity,	  has	  been	  shown	  to	  increase	  the	  
expression	   of	   some	   proteases	   associated	   with	   perlecan	   processing.	   Using	   a	   transient	   distal	  
middle	  cerebral	  artery	  occlusion	  (MCAo)	  model	  for	  focal	   ischemic	  stroke	  we	  show	  that	  while	  7	  
days	   of	   running	   only	   slightly	   decreased	   infarct	   volume,	   BMP1	   and	   perlecan	   (HSPG2)	   RNA	  
expression	  in	  skeletal	  muscle	  was	  significantly	  increased	  in	  3-­‐month-­‐old	  male	  wild	  type	  C57/BL6	  
mice.	  Moreover,	  elevated	   levels	  of	  BMP1	  RNA	  were	  still	  detectable	  after	  3	  days	  of	  detraining,	  
suggesting	  a	  prolonged	  effect	  of	  exercise	  on	  BMP1	  expression.	  Levels	  of	  LG3	  in	  the	  blood	  were	  
below	   the	   limit	   of	   detection	   in	   the	   current	   study,	   however	   it	   is	   likely	   that	   a	   more	   sensitive	  
method	  would	  enable	  analysis	  of	  serum.	  These	  preliminary	  findings	  suggest	  that	  LG3	  could	  be	  a	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CHAPTER	  1:	  INTRODUCTION	  
	  
Stroke	  Epidemiology	  and	  Etiology	  
While	  the	  prevalence	  of	  stroke	  has	  somewhat	  plateaued	  in	  the	  last	  20	  years,	  in	  part	  due	  to	  
widespread	  statin	  and	  anti-­‐platelet	  use,	  stroke	  remains	  a	  leading	  cause	  of	  death	  and	  disability	  in	  
the	  US.	  Stroke	  is	  the	  second	  leading	  cause	  of	  death	  worldwide,	  with	  around	  6.5	  million	  reported	  
deaths	   from	   stroke	   annually	   (Benjamin	   et	   al.,	   2017;	   Kochanek,	   Murphy,	   Xu,	   &	   Arias,	   2014;	  
Ovbiagele	  &	  Nguyen-­‐Huynh,	  2011).	  Stroke	  mortality	  is	  an	  issue	  in	  Kentucky	  in	  particular,	  as	  the	  
state	  is	  one	  of	  11	  within	  the	  “stroke	  belt”	  as	  designated	  by	  the	  National	  Heart,	  Lung	  and	  Blood	  
Institute.	   Stroke	   death	   rates	   are	   10%	  higher	   in	   the	   stroke	   belt	   than	   the	   national	   average	   and	  
numerous	  initiatives	  have	  been	  funded	  in	  an	  effort	  to	  increase	  education	  and	  reduce	  the	  risk	  of	  
stroke	  in	  these	  regions	  (NHLBI,	  1996;	  Thom	  et	  al.,	  2006).	  A	  stroke,	  by	  definition,	  is	  a	  loss	  of	  blood	  
flow	   in	   the	  brain	   that	   can	   cause	   a	   localized	   area	  of	   tissue	  death	   known	  as	   an	   infarct.	   Infarcts	  
generally	   occur	   when	   cerebral	   blood	   flow	   (CBF)	   is	   less	   than	   10	   mL/g	   of	   tissue	   per	   minute	  
(Latchaw	  et	  al.,	  2003).	  Consistent	  blood	  flow	  is	  fundamental	  in	  delivering	  oxygen	  and	  nutrients	  
to	   tissue	   along	  with	  providing	   an	   avenue	   for	  waste	   removal;	   absolutely	   essential	   processes	   in	  
tissues	  with	  high	  metabolic	  activity	  such	  as	  the	  brain.	  Loss	  of	  regular	  circulation	  can	  occur	  due	  to	  
the	  physical	  occlusion	  of	  a	  vessel	  to	  cause	  an	  ischemic	  stroke	  or	  vessel	  rupture	  in	  a	  hemorrhagic	  
stroke.	   Occlusions	   frequently	   occur	   in	  major	   intracranial	   arteries	   such	   as	   the	  middle	   cerebral	  
artery	   (MCA),	   internal	   carotid	   artery	   (ICA),	   basilar	   artery	   and	   anterior	   cerebral	   artery	   (ACA).	  
Emergent	   large	  vessel	  occlusion	  (ELVO)	  strokes	  are	  those	   in	  the	   ICA	  and	  proximal	  segments	  of	  
the	  MCA	  and	  are	  associated	  with	  high	  mortality	  and	  long-­‐term	  disability	  (Jayaraman	  et	  al.,	  2015;	  
Teleb,	  Ver	  Hage,	  Carter,	  Jayaraman,	  &	  McTaggart,	  2016).	  A	  majority	  of	  stroke	  research,	  including	  
this	  thesis,	  focuses	  on	  ischemic	  ELVO	  stroke,	  which	  make	  up	  87%	  of	  stroke	  cases	  (Ovbiagele	  &	  
Nguyen-­‐Huynh,	  2011).	  	  
	  2	  
Pathophysiology	  of	  Ischemia/Reperfusion	  Injury	  
In	  the	  core	  of	  the	   ischemic	   lesion,	   loss	  of	   ionic	  homeostasis	   leads	  to	  metabolic	  failure	  that	  
results	   in	   rapid	   tissue	   death	   from	   excitotoxicity,	  membrane	   integrity	   loss	   and	   various	   cellular	  
death	   mechanisms.	   Collateral	   vessels	   are	   able	   to	   maintain	   marginal	   blood	   flow	   to	   the	   peri-­‐
infarcted	   region,	   preserving	   some	   cellular	   integrity.	   This	   vulnerable	   tissue	   surrounding	   the	  
ischemic	  core,	  known	  as	  the	  penumbra,	  is	  considerably	  challenged	  metabolically	  and	  is	  sensitive	  
to	   biochemical	   signals	   coming	   from	   the	   surrounding	   tissue	   and	   vasculature	   as	   well	   as	   the	  
primary	  infarct	  itself.	  ATP	  depletion	  and	  ionic	  homeostasis	  are	  drastically	  compromised	  with	  the	  
loss	  of	  regular	  circulation.	  Dysregulation	  of	  the	  sodium	  potassium	  exchanger,	  in	  addition	  to	  the	  
buildup	  of	  CO2	  and	  lactate	  from	  anaerobic	  respiration,	  lowers	  the	  pH	  of	  the	  tissue	  and	  increases	  
the	  calcium	  load	  of	  cells	  and	  mitochondria	  (Kalogeris,	  Baines,	  Krenz,	  &	  Korthuis,	  2012;	  Sanada,	  
Komuro,	   &	   Kitakaze,	   2011).	   Along	   with	   disruption	   of	   membrane	   potential	   homeostasis,	   ionic	  
imbalance	  can	  drastically	  alter	  neurotransmitter	  release	  and	  reuptake,	  especially	  in	  the	  case	  of	  
the	   excitatory	   neurotransmitter	   glutamate.	   Elevated	   extracellular	   glutamate	   levels	   can	   cause	  
toxic	   overstimulation	  of	   surrounding	   cells,	  which	   are	   already	  depleted	  of	  ATP	   and	  overloaded	  
with	   calcium,	   in	   a	   process	   known	   as	   excitotoxicity	   (Dugan,	   1999;	   Xing,	   Arai,	   Lo,	   &	   Hommel,	  
2012).	   These	   biological	   processes	   can	   lead	   to	   cellular	   swelling	   and	   rupture	   and	   can	   elicit	  
widespread	  necrosis,	  but	  also	  apoptosis	  and	  autophagy;	  mechanisms	  that	  are	  all	  present	  in	  the	  
ischemic	  core	  (Deng,	  He,	  Yang,	  &	  Zhang,	  2016;	  Xu	  &	  Zhang,	  2011).	  The	  complexity	  of	   ischemic	  
injury	   is	   further	   complicated	  when	   incorporating	   the	   variable	  of	   reperfusion	  of	  blood	   in	   cases	  
where	   the	   occlusion	   is	   cleared.	   While	   the	   restoration	   of	   blood	   flow	   provides	   much	   needed	  
oxygen	  and	  glucose	  and	  can	   reestablish	   ionic	  homeostasis,	  pH	   levels	  and	  eliminate	  waste	  and	  
debris;	  reperfusion	  can	  further	  exacerbate	  tissue	  damage	  as	  the	  sudden	  changes	  can	  generate	  
reactive	   oxygen	   species	   (ROS)	   and	   proinflammatory	   signals	   to	   prompt	   additional	   tissue	   death	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(Kalogeris	  et	  al.,	  2012;	  Xing	  et	  al.,	  2012).	  Not	  only	  can	  reperfusion	  specifically	  trigger	  apoptotic	  
pathways	   in	   neurons	   and	   resident	   glial	   cells;	   changes	   in	   the	   vasculature	   itself	   can	   exacerbate	  
stress	  and	  damage	  (Manabat	  et	  al.,	  2003;	  H.	  Morrison,	  McKee,	  &	  Ritter,	  2011;	  H.	  W.	  Morrison	  &	  
Filosa,	  2013).	  Damage	  from	  both	  the	  initial	  ischemia	  and	  subsequent	  reperfusion	  cause	  the	  cells	  
in	   the	  penumbra	   to	  die	   slowly	  over	   several	  days	  as	   the	   infarct	  matures,	   inevitably	   resulting	   in	  
expansion	  of	  the	  ischemic	  lesion.	  Many	  of	  these	  more	  chronic	  injury	  mechanisms	  are	  mediated	  
through	  alterations	  in	  the	  vasculature	  and	  there	  is	  significant	  research	  that	  suggests	  minimizing	  
these	   changes	   significantly	   reduces	   injury	   and	   disability	   from	   ischemic	   stroke	   (Lo,	   Dalkara,	   &	  
Moskowitz,	  2003;	  Mehta	  &	  Vemuganti,	  2014).	  
The	  Neurovascular	  Unit	  
Though	   vasculature	   was	   historically	   thought	   of	   as	   a	   straightforward	   and	   relatively	   inert	  
tissue,	   extensive	   research	   has	   shown	   that	   the	   neurovascular	   unit	   (NVU)	   produces	   intricate,	  
specific	   signals	   to	  and	   from	  surrounding	   tissue	  and	   the	  whole	  body.	  The	  neurovascular	  unit	   is	  
comprised	   in	  part	  of	  endothelial	   cells,	  pericytes,	  closely	  associated	  glial	   cells,	  neurons	  and	   the	  
surrounding	  extracellular	  matrix	  (ECM)	  (Lakhan,	  Kirchgessner,	  Tepper,	  &	  Leonard,	  2013;	  Muoio,	  
Persson,	  &	   Sendeski,	   2014).	   The	   endothelium	  makes	  up	   the	   innermost	   layer	   of	   blood	   vessels.	  
Endothelial	   cells	   in	   the	   brain	   are	   exceptionally	   polarized,	   have	   increased	   numbers	   of	  
mitochondria,	   are	   thinner,	   and	   have	   fewer	   fenestrations	   and	   endocytic	   vesicles	   than	   those	   in	  
the	   microvasculature	   of	   other	   parts	   of	   the	   body	   (Coomber	   &	   Stewart,	   1986;	   Roggendorf	   &	  
Cervós-­‐Navarro,	   1977).	   All	   of	   these	   properties	   indicate	   that	   brain	   endothelia	   actively	   regulate	  
the	   transcellular	   transport	   of	   various	   blood	   constituents	   into	   the	   brain	   parenchyma.	  
Additionally,	  specialized	  proteins	  are	  expressed	  at	  the	  junctions	  of	  these	  flat	  endothelial	  cells	  to	  
create	   a	   seal	   that	   is	   relatively	   impermeable	   to	   the	   passive	   paracellular	   diffusion	   of	   most	  
molecules	   and	  many	   small	   ions.	   Transmembrane	   proteins	   such	   as	   the	   claudins,	   occludin	   and	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cadherins	  are	  the	  main	  components	  of	  tight	  junctions	  and	  are	  tethered	  to	  the	  actin	  cytoskeleton	  
via	   cytoplasmic	   adapter	   molecules.	   Tight	   junction	   proteins	   interact	   strongly	   through	  
extracellular	   loops	   to	   significantly	   reduce	  paracellular	   transport	   and	  also	  help	   to	  maintain	   the	  
polarity	   of	   the	   apical	   to	   basal	   side	   of	   the	   endothelial	   cells.	   Redistribution	   and	   reduced	  
expression	  of	   tight	   junction	  proteins	  have	  been	  demonstrated	  after	   stroke	  and	  other	   cerebral	  
inflammatory	   disorders	   and	   are	   associated	   with	   increased	   edema,	   leukocyte	   infiltration,	  
inflammation	   and	  overall	   infarct	   volume	   (Jiao,	  Wang,	   Liu,	  Wang,	  &	  Xue,	   2011;	  Neuwelt	   et	   al.,	  
2011;	   Stamatovic,	   Keep,	   Wang,	   Jankovic,	   &	   Andjelkovic,	   2009;	   Wong	   et	   al.,	   2013;	   Yang	   &	  
Rosenberg,	   2011).	   A	   layer	   of	   basal	   lamina	   ECM	   surrounds	   the	   endothelial	   cells	   to	   provide	  
structure	   and	   support	   to	   the	   neurovascular	   unit.	   The	   basal	   lamina	   is	   made	   up	   primarily	   of	  
laminin,	   fibronectin,	   collagen	   and	   heparin	   sulfate	   proteoglycans.	   Degradation	   of	   the	   basal	  
lamina	   and	   tight	   junctions	   by	   proteases	   such	   as	   the	   matrix	   metalloproteases	   (MMPs)	   are	  
associated	   with	   edema	   and	   leukocyte	   extravasation	   and	   can	   also	   prompt	   anoikis	   (Abbott,	  
Ronnback,	  &	  Hansson,	   2006;	   Chen,	  Ohashi,	   Li,	   Eckman,	  &	  Nguyen,	   2009;	   Lo	   et	   al.,	   2003).	   The	  
complexity	  of	  the	  neurovascular	  unit	  is	  markedly	  increased	  by	  additional	  interactions	  from	  cells	  
such	  as	  pericytes,	  astrocytes,	  microglia	  and	  neurons	   themselves.	  These	  cells	   can	   influence	   the	  
expression	   of	   tight	   junctions	   and	   ECM	   proteins,	   influence	   transcellular	   transport	   across	   the	  
endothelium,	  release	  bioactive	  factors	  and	  effect	  vasodilation	  (Abbott	  et	  al.,	  2006;	  Ben-­‐Zvi	  et	  al.,	  
2014;	  Cheng	  et	  al.,	  2006).	  All	  together,	  these	  cells	  and	  proteins	  maintain	  a	  stable	  environment	  
for	  the	  surrounding	  brain	  tissue	  by	  creating	  a	  blood	  brain	  barrier	  (BBB)	  that	  restricts	  the	  passage	  
of	  many	  circulating	  elements	   into	  the	  brain	  parenchyma.	  All	  of	  the	  aforementioned	  properties	  
influence	   permeability	   of	   the	   BBB	   after	   ischemia.	   The	   BBB	   does	   not	   follow	   a	   simple	   open	   or	  
closed	  configuration,	  as	  it	  is	  constantly	  responding	  to	  signals.	  The	  dynamic	  responses	  of	  the	  NVU	  
are	  evident	  as	  the	  BBB	  shows	  a	  biphasic	  opening	  pattern	  after	  stroke.	  First,	  a	  transient	  opening	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occurs	   several	   hours	   after	   reperfusion.	   After	   an	   interval	   of	   24	   to	   48	   hours,	   a	   second,	   more	  
sustained	   increase	   in	   permeability,	   associated	   with	   increased	   vessel	   damage,	   takes	   place	  
(Huang,	  Xue,	  Preston,	  Karbalai,	  &	  Buchan,	  1999;	  Knowland	  et	  al.,	  2014;	  Zlokovic,	  2008).	  Overall,	  
increased	  permeability	  of	  the	  BBB	  after	  stroke	  is	  associated	  with	  extended	  tissue	  damage	  due	  to	  
edema	  and	  inflammation	  (Baeten	  &	  Akassoglou,	  2011;	  Cuomo	  et	  al.,	  2015).	  Furthermore,	  after	  
an	   ischemic	   event,	   upregulation	   of	   adhesion	   molecules	   on	   endothelial	   cells	   facilitate	   the	  
infiltration	  of	  peripheral	  leukocytes	  that	  can	  go	  on	  to	  trigger	  a	  cascade	  of	  inflammatory	  signaling	  
and	   damage	  within	   the	   brain	   (Henninger	   et	   al.,	   1997;	   Stanimirovic,	  Wong,	   Shapiro,	  &	  Durkin,	  
1997).	  	  
Contributions	  of	  Perlecan	  to	  Stroke	  Neuroprotection	  
As	   previously	   mentioned,	   activation	   and	   release	   of	   numerous	   proteases	   capable	   of	  
degrading	   the	   ECM	  can	  not	   only	   break	  down	   the	  BBB,	   but	   can	   also	   release	  biologically	   active	  
fragments	   from	   ECM	   components.	   A	   segment	   of	   one	   such	   ECM	   protein,	   perlecan,	   has	  
demonstrated	  profound	  neuroprotective	  effects	  when	  administered	  after	  transient	   ischemia	  in	  
rodent	  models	  of	   stroke	   (Bix,	  Gowing,	  &	  Clarkson,	  2013;	  Clarke	  et	   al.,	   2012;	   Lee	  et	   al.,	   2011).	  
Perlecan	   is	   a	   heparan	   sulfate	   proteoglycan	   that	   is	   expressed	   ubiquitously	   in	   basement	  
membranes	  throughout	  the	  body.	  Proteolytic	  processing	  by	  proteases	  such	  as	  stromelysin	  and	  
plasmin	  have	  been	  shown	  to	  release	  the	  C-­‐terminal	  domain	  of	  perlecan:	  domain	  V	  (DV)	  (Fukuda	  
et	  al.,	  2004;	  Whitelock,	  Murdoch,	  Iozzo,	  &	  Underwood,	  1996).	  DV	  can	  be	  further	  subdivided	  into	  
three	  laminin-­‐like	  globular	  domains,	  where	  the	  terminal	  domain,	  LG3,	  shown	  to	  be	  cleaved	  and	  
released	  from	  DV	  by	  bone	  morphogenic	  protein-­‐1	  (BMP-­‐1),	  cathepsin	  B	  (CTSB)	  and	  cathepsin	  L	  
(CTSL),	   possesses	   the	   highest	   level	   of	   biological	   activity	   (Cailhier	   et	   al.,	   2008;	   Gonzalez	   et	   al.,	  
2005;	  Gu	  et	  al.,	  2015;	  Saini	  &	  Bix,	  2012).	  When	  administered	  after	  experimental	  stroke,	  DV	  has	  
been	  shown	  to	   localize	  specifically	   to	   ischemic	  regions	  and	  significantly	  reduce	   infarct	  volume,	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reduce	  motor	  and	  cognitive	  deficits,	  increase	  angiogenesis	  and	  reduce	  inflammation	  (Bix	  et	  al.,	  
2013;	  Clarke	  et	  al.,	  2012;	  Lee	  et	  al.,	  2011).	  These	  actions	  have	  been	  shown	  to	  be	  accomplished,	  
in	   part,	   by	   interaction	  with	   the	  α5β1	   integrin	  where	   activation	   of	   ERK-­‐signaling	   pathways	   can	  
lead	   to	   the	   release	   of	   vascular	   endothelial	   growth	   factor	   (VEGF),	   a	   known	   mediator	   of	  
neurorepair	  (Clarke	  et	  al.,	  2012;	  Zoeller,	  Whitelock,	  &	  Iozzo,	  2009).	  DV	  has	  also	  been	  shown	  to	  
act	  directly	  on	  astrocytes	  via	  the	  α2β1	  integrin	  as	  well	  as	  α5β1	  to	  reduce	  astrogliosis	  and	  induce	  
nerve	  growth	   factor	   secretion	   (Al-­‐Ahmad,	   Lee,	   Saini,	  &	  Bix,	  2011).	  Recently,	   running	  has	  been	  
shown	   to	   increase	   the	   expression	   and	   release	   of	   the	   LG3	   cleaving	   CTSB	   into	   circulation	   in	  
humans,	   rodents	   and	   non-­‐human	   primates.	   Furthermore,	   the	   levels	   of	   CTSB	   in	   plasma	  
correlated	   with	   increased	   memory	   function	   in	   humans	   (Moon	   et	   al.,	   2016).	   There	   is	   also	  
evidence	  of	  increases	  in	  CTSL	  and	  BMP-­‐1	  expression	  from	  exercise	  (Iijima	  et	  al.,	  2016;	  Schwalm	  
et	  al.,	  2015).	  As	  proteases,	   it	   is	   likely	  that	  these	  proteins	  are	  acting	  on	  other	  factors	  to	  release	  
bioactive	  fragments.	  Whether	  LG3	  is	  one	  of	  the	  effectors	  released	  in	  association	  with	  exercise	  is	  
unknown.	  	  
Exercise	  Preconditioning	  
Risk	  factors	  for	  stroke	  include	  age,	  sex,	  ethnicity,	  smoking,	  hypertension,	  physical	  inactivity	  
and	  diabetes	  among	  others	  (Goldstein	  et	  al.,	  2006).	  While	  some	  risk	  factors	  are	  non-­‐modifiable,	  
several	   factors	   are	   associated	   with	   poor	   cardiovascular	   health	   that	   in	   many	   cases	   can	   be	  
attributed	   to	   low	   levels	   of	   physical	   activity.	   The	   neuroprotective	   effects	   of	   exercise	  
preconditioning	  have	  been	  studied	  considerably.	  It	  has	  been	  shown	  that	  patients	  that	  exercised	  
in	  the	  2	  weeks	  prior	  to	  an	  ischemic	  event	  show	  decreased	  stroke	  risk	  and	  severity	  (Deplanque,	  
Masse,	   Libersa,	   Leys,	   &	   Bordet,	   2012;	   Sacco	   et	   al.,	   1998).	   These	   patients	   showed	   reduced	  
neurodeficit	   upon	  hospital	   admittance	   and	   increased	   independence	  one	  week	   after	   stroke.	   In	  
addition,	  those	  that	  exercised	  had	  lower	  body	  mass	  indices	  and	  were	  less	  likely	  to	  have	  various	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modifiable	   stroke	   risk	   factors	   such	  as	  diabetes,	  hypertension	  and	  heart	  disease	   (Deplanque	  et	  
al.,	   2012;	   Stroud	   et	   al.,	   2009).	   Furthermore,	   reduced	   infarct	   volumes,	   memory	   and	   motor	  
deficits,	   apoptosis,	   and	   inflammation	   have	   all	   been	   demonstrated	   in	   animal	  models	   of	   stroke	  
(Curry	   et	   al.,	   2010;	   Y.	   H.	   Ding	   et	   al.,	   2005;	   Hayes	   et	   al.,	   2008;	   Liebelt	   et	   al.,	   2010;	   Shamsaei,	  
Khaksari,	  Erfani,	  Rajabi,	  &	  Aboutaleb,	  2015).	  Exercise	  has	  been	  shown	  to	  increase	  neurotrophic	  
factors	  such	  as	  brain-­‐derived	  neurotrophic	  factor	  (BDNF)	  and	  nerve	  growth	  factor	  (NGF)	  (Y.	  Ding	  
et	  al.,	  2004;	  Otsuka	  et	  al.,	  2016),	  decrease	  BBB	  leakiness	  (Wolff,	  Davidson,	  Wrobel,	  &	  Toborek,	  
2015;	  Yuling	  Zhang	  et	  al.,	  2013),	  reduce	  neuroinflammation	  (Chio	  et	  al.,	  2017;	  B.	  C.	  Mota	  et	  al.,	  
2012;	  Zhao,	  Sabirzhanov,	  Wu,	  Faden,	  &	  Stoica,	  2015),	  attenuate	  oxidative	  stress	  (Endres	  et	  al.,	  
2003;	   Feng	   et	   al.,	   2014),	   and	   to	   reduce	   resident	  microglia	   activation	   (Kohman,	   Bhattacharya,	  
Wojcik,	   &	   Rhodes,	   2013;	   Zhao	   et	   al.,	   2015).	  While	   the	   association	   of	   exercise	   with	   improved	  
cardiovascular	   health,	   therein	   reduced	   stroke	   risk,	   is	   generally	   accepted,	   the	   molecular	  
mechanisms	  that	  underlie	  this	  neuroprotective	  effect	  are	  multitudinous.	  Numerous	  studies	  have	  
identified	   various	   myokines;	   small	   peptides	   released	   from	   skeletal	   muscle	   into	   circulation	   in	  
response	  to	  muscle	  contractions	  associated	  with	  exercise	  (Endres	  et	  al.,	  2003;	  Moon	  et	  al.,	  2016;	  
Schnyder	  &	  Handschin,	  2015).	  Identification	  and	  characterization	  of	  a	  secreted	  component	  that	  
influences	   a	   range	  of	   neuroprotective	  mechanisms	  would	  be	  of	   great	   interest	   for	   adaption	   to	  
therapeutic	  use.	  	  
Study	  Summary	  
We	  hypothesize	  that	  exercise	  will	  increase	  the	  production	  and	  release	  of	  LG3	  from	  skeletal	  
muscle	  into	  systemic	  circulation	  through	  the	  increased	  expression	  of	  proteases	  associated	  with	  
LG3	  cleavage.	  We	  expect	  circulating	  LG3	  to	  localize	  to	  the	  infarcted	  regions	  where	  the	  levels	  of	  
which	   are	   also	   expected	   to	   correlate	   with	   reduced	   stroke	   volume,	   BBB	   breakdown	   and	  
neuroinflammation.	  Here,	  changes	  in	  RNA	  and	  protein	  expression	  were	  evaluated	  after	  7	  days	  of	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running	  wheel	  exposure	   in	  3-­‐month-­‐old	  wild	   type	  male	  C57/BL6	  mice.	  Expression	  of	   the	  CTSB	  
and	  BMP-­‐1	  proteases	  in	  type	  II	  fast	  twitch	  gastrocnemius	  muscle	  were	  evaluated	  in	  stroked	  and	  
naïve	   mice	   using	   real-­‐time	   polymerase	   chain	   reaction	   (PCR)	   and	   protein	   immunobloting.	   A	  
transient	  distal	  middle	  cerebral	  artery	  occlusion	  model	  (MCAo)	  was	  used	  to	  evaluate	  the	  effect	  
of	   running	  specifically	  on	  focal	  cortical	   ischemia/reperfusion	   injury	   in	  contrast	   to	  a	  majority	  of	  
previous	   studies	   that	   have	   utilized	   global	   and	   central	   cerebral	   ischemia	  models.	   Ischemic	   and	  
peri-­‐infarcted	   cortical	   regions	  were	   evaluated	   for	  markers	   of	   inflammation	   and	   BBB	   integrity.	  
The	  aim	  of	  this	  study	  was	  to	  investigate	  the	  potential	  of	  exercise	  to	  induce	  LG3	  release	  and	  to	  
correlate	   these	  measures	  with	  markers	  of	   stroke	  pathology.	  A	  graphical	   representation	  of	   the	  
study	  hypotheses	  is	  depicted	  in	  Figure	  1.1.	  





Figure	  1.1	  Overall	  study	  hypotheses.	  	  
Exercise,	   in	   the	   form	  of	   voluntary	   running,	   is	   expected	   to	   increase	   the	  expression	  of	   perlecan	  
cleaving	  proteases	  in	  skeletal	  muscles	  utilized	  during	  physical	  activity.	  This	  increase	  in	  protease	  
expression	  is	  anticipated	  to	  result	  in	  the	  generation	  of	  the	  LG3	  fragment	  of	  perlecan	  that	  will	  be	  
subsequently	  released	  into	  systemic	  circulation.	  Localization	  of	  LG3	  to	  regions	  of	  the	  brain	  that	  
have	   undergone	   an	   ischemic	   insult	   is	   predicted	   to	   reduce	   stroke	   volume	   by	   reducing	   BBB	  
breakdown	  and	  neuroinflammation	  of	  the	  NVU.	  

















CHAPTER	  2:	  MATERIALS	  AND	  METHODS	  
Animals	  and	  Exercise	  Paradigm	  
All	  experimental	  procedures	  were	  performed	  in	  accordance	  with	  the	  University	  of	  Kentucky	  
Division	  of	  Laboratory	  Animal	  Research,	  Institutional	  Animal	  Care	  and	  Use	  Committee	  guidelines	  
under	  protocol	  number	  2015-­‐2156.	  12-­‐week-­‐old	  male	  C57/BL6	  mice	  from	  Jackson	  Laboratories	  
were	   housed	   individually	   in	   mouse	   single	   activity	   wheel	   chambers	   (Lafayette	   Instruments,	  
Lafayette,	   IN)	   with	   disassembled	   running	   wheels	   for	   1	   week	   of	   acclimation	   prior	   to	   any	  
experiments	  and	  were	  provided	   food	  and	  water	  ab	   libitum	   for	   the	  duration	  of	   study.	  Animals	  
were	  separated	  into	  5	  groups	  (Figure	  2.1),	  consisting	  of	  3	  naïve	  groups:	  7	  days	  of	  free	  access	  to	  
running	  wheel	   (7d	   RW,	   n=4);	   sedentary	   controls	   that	  were	   housed	   in	   identical	   running	  wheel	  
cages	   for	   7	   days	   where	   the	   running	   wheel	   had	   been	   removed	   in	   order	   to	   control	   for	   single	  
housing	  (sedentary,	  n=4);	  and	  7	  days	  of	  free	  running	  wheel	  access	  with	  wheel	  removal	  on	  day	  7	  
followed	  by	  3	  sedentary	  days	  in	  order	  to	  reproduce	  the	  3	  day	  sedentary	  interval	  experienced	  by	  
the	  surgery	  groups	  (7d	  RW	  +	  3d	  sed.).	  The	  two	  surgery	  groups	  included:	  7	  days	  of	  free	  access	  to	  
running	  wheel	  with	  wheel	  removal	  and	  MCAo	  on	  day	  7	  followed	  by	  a	  3	  day	  sedentary	  period	  (7d	  
RW	   +	   MCAo,	   n=6),	   and	   7	   days	   of	   sedentary	   control	   with	   MCAo	   on	   day	   7	   followed	   by	   an	  
additional	  3	  days	  of	  sedentary	  housing	  (sedentary	  +	  MCAo,	  n=6).	  As	  the	  aim	  of	  the	  current	  study	  
was	   to	   analyze	   the	  effects	  of	   exercise	  prior	   to	   stroke	   it	  was	  necessary	   to	   remove	   the	   running	  
wheels	  after	  surgery	  in	  order	  to	  focus	  on	  preconditioning	  rather	  than	  introduce	  the	  variable	  of	  
exercise	   rehabilitation	   after	   stroke.	   Animals	   with	   access	   to	   a	   running	   wheel	   are	   considered	  
“exercised”	   in	   the	   current	   study.	   Running	   wheel	   revolutions	   were	   detected	   and	   recorded	   by	  
Lafayette	   Instruments	   Activity	   Wheel	   Monitor	   software	   v11.12.	   Animals	   ran	   voluntarily	   and	  




Figure	  2.1	  Running	  wheel	  study	  design.	  	  
Animals	  were	  housed	  in	  cages	  where	  running	  wheels	  had	  been	  disassembled	  during	  sedentary	  
intervals	  to	  control	  for	  the	  effects	  of	  single	  housing.	  Serum	  was	  taken	  via	  submandibular	  punch	  
prior	   to	   sacrifice.	   Naïve	   groups	   (7d	   RW,	   sedentary	   and	   7dRW	   +	   3d	   sed.)	   were	   transcardially	  
perfused	   with	   phosphate	   buffered	   saline	   (PBS)	   prior	   to	   tissue	   harvesting;	   cervical	   dislocation	  
without	  perfusion	  was	  performed	  on	  MCAo	  groups	  (7d	  RW	  +	  MCAo	  and	  sedentary	  +	  MCAo).	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Model	  of	  Cerebral	  Ischemia	  
Mice	  from	  the	  7d	  RW	  +	  MCAo	  and	  sedentary	  +MCAo	  groups	  were	  anesthetized	  with	  an	  87.5	  
mg/kg	  ketamine/12.5	  mg/kg	  xylazine	  cocktail	  via	  intraperitoneal	  injection.	  Ischemia/reperfusion	  
was	   induced	   via	   the	   transient	   tandem	   ipsilateral	   common	   carotid	   artery	   (CCA)/MCA	   model	  
(Waxham,	  Grotta,	  Silva,	  Strong,	  &	  Aronowski,	  1996)	  for	  60	  minutes	  followed	  by	  reperfusion	  for	  3	  
days	  to	  post	  stroke	  day	  3	  (PSD3).	  MCAo	  was	  performed	  between	  5	  and	  8	  hours	  after	  the	  end	  of	  
the	  light	  cycle.	  Briefly,	  a	  small	  burr	  hole	  was	  drilled	  over	  the	  left	  MCA	  and	  a	  0.005-­‐inch	  diameter	  
stainless-­‐steel	  wire	  filament	  was	  slid	  under	  the	  MCA	  and	  placed	  over	  the	  skull	  using	  the	  sides	  of	  
the	  gap	  created	  by	  the	  burr	  hole	  to	  elevate	  the	  MCA	  and	  create	  tension	  to	  occlude	  the	  artery.	  A	  
>80%	  reduction	  of	  blood	  flow	  was	  confirmed	  via	  laser-­‐Doppler	  flowmetry	  using	  a	  Laser	  Doppler	  
Perfusion	  Monitor	   (Perimed,	   Ardmore,	   PA)	   placed	   distally	   to	   the	   filament.	   The	   CCA	  was	   then	  
isolated	  and	  occluded	  with	  an	  aneurysm	  clip	  to	  reduce	  collateral	  perfusion	  of	  the	  MCA	  territory	  
by	   the	   ACA.	   After	   60	   minutes,	   both	   the	   CCA	   clip	   and	   MCA	   filament	   were	   removed	   and	  
reestablishment	   of	   >75%	   original	   blood	   flow	   was	   confirmed	   using	   laser-­‐Doppler	   flowmetry.	  
Infarct	   volumes	   were	   analyzed	   on	   PSD3	   using	   2,3-­‐triphenyltetrazolium	   chloride	   (TTC),	   where	  
tissue	   with	   functional	   mitochondria	   stains	   a	   red	   color	   and	   infarcted	   tissue	   with	   damaged	  
mitochondria	  remains	  white.	  Brains	  were	  cut	  into	  2-­‐mm	  thick	  coronal	  sections	  and	  stained	  with	  
TTC	  for	  12-­‐15	  minutes	  at	  room	  temperature.	  Infarct	  volumes	  were	  calculated	  using	  three	  2mm	  
coronal	  brain	  sections	  by	  computer-­‐assisted	  volumetry	  using	  the	  following	  equation:	  




Equation	  2.1	  Infarct	  volumes	  were	  normalized	  for	  swelling	  using	  the	  above	  equation	  where	  𝑑𝑑	  is	  the	  
thickness	   of	   the	   section	   (2	   mm),	  𝐹𝐹! 	   is	   the	   measured	   area	   of	   ischemia,	   𝐼𝐼! 	   is	   the	   total	   area	   of	   the	  
ipsilateral	  hemisphere,	  and	  𝐶𝐶! 	  is	  the	  total	  area	  of	  the	  contralateral	  hemisphere	  for	  slice	  i.	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Tissue	  Processing	  
In	   accordance	   with	   the	   timing	   depicted	   in	   figure	   2.1,	   naïve	   animals	   from	   the	   7d	   RW,	  
sedentary	   and	  7d	  RW	  +	  3d	   sed.	   groups	  were	  deeply	   anesthetized	  with	   ketamine/xylazine	  and	  
transcardially	  perfused	  with	  PBS	  prior	  to	  isolation	  of	  gastrocnemius	  muscles.	   In	  order	  to	  utilize	  
TTC	   staining	   for	   robust	   infarct	   visualization,	   perfusion	   was	   not	   performed	   on	   MCAo	   groups;	  
therefore	  these	  animals	  were	  sacrificed	  via	  cervical	  dislocation.	  After	  TTC	  staining,	  the	  infarcted	  
cortex	   along	   with	   a	   modest	   amount	   of	   peri-­‐infarcted	   tissue	   was	   dissected	   from	   each	   brain	  
section.	  All	  brain	   tissue	  and	  gastrocnemius	  muscles	  were	   flash	   frozen	   in	   liquid	  nitrogen.	  Blood	  
was	  collected	  prior	  to	  sacrifice	  via	  a	  submandibular	  punch	  into	  serum	  separator	  tubes,	  allowed	  
to	  clot	  and	  centrifuged	  at	  2000	  rcf	   for	  15	  minutes	  at	  25°C.	  Serum	  and	  all	   tissue	  samples	  were	  
stored	  at	  -­‐20°C.	  
Reverse	  and	  Real-­‐time	  Transcription	  Polymerase	  Chain	  Reaction	  (PCR)	  
Total	  RNA	  was	   isolated	   from	  tissue	  using	  a	   rotor	   tissue	  homogenizer	  and	  Trizol™	  Reagent	  
(ThermoFisher,	  Carlsbad,	  CA)	  with	  a	  5:1	  ratio	  of	  chloroform.	  RNA	  was	  then	  purified	  using	  a	  spin	  
column-­‐based	  PureLink™	  RNA	  Mini	  kit	  (Life	  Technologies,	  Carlsbad,	  CA).	  RNA	  concentration	  was	  
measured	  using	  a	  NanoDrop™	   spectrophotometer.	   cDNA	  was	  produced	  using	  a	  High-­‐Capacity	  
cDNA	   Reverse	   Transcription	   kit	   (Life	   Technologies,	   Carlsbad,	   CA)	   according	   to	  manufacturer’s	  
instructions.	   Real-­‐time	   PCR	  was	   performed	   using	   FAM™-­‐MGB	   reporter-­‐quencher	   probes	  with	  
TaqMan™	  Fast	  Advance	  Master	  mix	  using	  50	  ng	  total	  RNA	  per	  sample.	  Target	  amplification	  was	  
performed	   using	   the	   ViiA™	   7	   Real-­‐Time	   PCR	   system	   and	   associated	   software	   v1.2	   (Applied	  
Biosystems,	  Grand	  Island,	  NY).	  Thermal	  cycling	  conditions	  were	  as	  follows:	  95°C	  holding	  stage,	  
40	   cycles	   of	   1	   second	   95°C	   denaturing	   and	   60°C	   annealing/primer	   extension	   for	   20	   seconds.	  
Table	  2.1	  describes	  the	  genes	  analyzed	  along	  with	  RefSeq	  and	  TaqMan	  identifiers.	   	  
	  14	  
Table	  2.1	  List	  of	  genes	  probed	  in	  real-­‐time	  PCR	  assays.	  
GENE	  OF	  INTEREST	   REFSEQ	  ID	   TAQMAN	  ID	  
Cathepsin	  B	  (CTSB)	   NM_007798.3	   Mm01310506_m1	  
Bone	  Morphogenic	  Protein	  1	  (BMP1)	   NM_009755.3	   Mm00802220_m1	  
Perlecan	  (HSPG2)	   NM_008305.3	   Mm01181173_g1	  
Peroxisome	  Proliferative	  Activated	  
Receptor	  Gamma,	  Co-­‐activator	  1	  
Alpha	  (PPARGC1A)	  
NM_008904.2	   Mm01208835_m1	  
Occludin	  (OCLN)	   NM_008756.2	   Mm00500912_m1	  
Claudin-­‐5	  (CLDN5)	   NM_013805.4	   Mm00727012_s1	  
Matrix	  Metallopeptidase	  9	  (MMP9)	   NM_013599.3	   Mm00442991_m1	  
Intracellular	  Adhesion	  Molecule	  2	  
(ICAM2)	  
NM_010494.1	   Mm00494862_m1	  
Vascular	  Cell	  Adhesion	  Molecule	  1	  
(VCAM1)	  
NM_011693.3	   Mm01320970_m1	  
Integrin	  alpha	  5	  (ITGA5)	   NM_010577.3	   Mm00439797_m1	  
	  
Gene	  expression	  normalized	  to	  18S	  rRNA	  or	  RPL38	  ribosomal	  protein.	  Probe	  sequences	  are	  
proprietary	  information	  of	  Thermo	  Fisher	  Scientific.	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Western	  Immunoblots	  
Lysates	  were	   prepared	   from	   flash	   frozen	   tissue	   in	   ice-­‐cold	   RIPA	   lysis	   buffer	  with	   protease	  
inhibitor	   cocktail	   (Roche	  Diagnostics,	  Mannheim,	  Germany)	   using	   a	   rotor	   tissue	   homogenizer.	  
Homogenates	  were	  centrifuged	  at	  20000	  x	  g	  for	  15	  minutes	  at	  4°C.	  Pierce™	  bicinchoninic	  acid	  
(BCA)	  protein	  assay	  kit	  was	  used	   to	  determine	  protein	   concentration.	  30	  µg	   total	  protein	  was	  
mixed	   with	   glycerol/SDS	   protein	   loading	   buffer	   (LI-­‐COR,	   Lincoln,	   NE)	   and	   denatured	   with	   2-­‐
Mercaptoethanol	   at	   95°C	   for	   5	   minutes.	   Samples	   were	   loaded	   into	   4-­‐20%	   Mini-­‐PROTEAN®	  
TGX™	  precast	  gels	  (Bio-­‐Rad,	  Hercules,	  CA),	  SDS-­‐PAGE	  was	  used	  to	  separate	  proteins,	  and	  iBlot®	  
transfer	  system	  was	  used	  to	  transfer	  proteins	  to	  a	  nitrocellulose	  membrane.	  Membranes	  were	  
blocked	  in	  LI-­‐COR	  Odyssey®	  Blocking	  Buffer	  (Lincoln,	  NE)	  for	  1	  hour	  at	  room	  temperature	  on	  an	  
orbital	  shaker.	  Primary	  antibodies	  were	  incubated	  in	  blocking	  buffer	  with	  0.1%	  Tween	  overnight	  
at	   4°C	  on	   a	   see-­‐saw	   shaker.	  Membranes	  were	   probed	  with	   anti-­‐pan	   cathepsin	   antibody	   (H-­‐1)	  
sc376803,	  1:250	  dilution	  (Santa	  Cruz	  Biotechnology,	  Santa	  Cruz,	  CA)	  and	  anti-­‐LG3	  antibody	  (H-­‐
300)	   sc-­‐25848,	   1:250	   dilution	   (Santa	   Cruz	   Biotechnology,	   Santa	   Cruz,	   CA).	   An	   anti-­‐GAPDH	  
antibody,	   1:10000,	   was	   used	   for	   gastrocnemius	   protein	   normalization	   (GeneTex,	   Ivine,	   CA).	  
Near-­‐infrared	  fluorescent	  secondary	  antibodies	  (LI-­‐COR,	  Lincoln,	  NE)	  were	  incubated	  for	  1	  hour	  
at	  room	  temperature	  in	  blocking	  buffer	  with	  0.1%	  Tween	  and	  0.01%	  SDS.	  Visualization	  using	  the	  
LI-­‐COR	  Odyssey®	  Infrared	  Imaging	  System	  was	  used	  for	  semi-­‐quantitative	  protein	  concentration	  
analyses.	  
Statistical	  Analysis	  
Data	  are	  presented	  as	  mean	  ±	  standard	  deviation	  unless	  otherwise	  noted.	  Statistical	  analysis	  
was	   performed	   using	   GraphPad	   Prism	   statistical	   package	   version	   7.0b	   for	  Mac	   OS	   (GraphPad	  
Prism,	  La	  Jolla,	  CA).	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CHAPTER	  3:	  RESULTS	  
Validation	  of	  Running	  Wheel	  Group	  Comparisons	  
Daily	   running	  wheel	  distances	  were	   logged	  and	  compared	   for	  variation	  between	  groups	   in	  
order	   to	   confirm	   that	   animals	   exercised	   at	   similar	   levels	   (Figure	   3.1).	   Animals	   that	   were	  
sacrificed	   immediately	   after	   a	   7-­‐day	   running	  wheel	   interval	   (7d	   RW	   group)	   ran	   an	   average	   of	  
8263	  ±	  1198	  meters	  per	  day	  and	  a	  7-­‐day	  cumulative	  average	  of	  49.7	  ±	  9.9	  km,	  n=4.	  Animals	  that	  
were	  subjected	  to	  MCAo	  after	  the	  7-­‐day	  running	  wheel	  interval	  and	  were	  then	  housed	  in	  cages	  
without	   running	  wheels	   for	  3	  days	  prior	   to	  sacrifice	   (7d	  RW	  +	  MCAo	  group)	   ran	  an	  average	  of	  
7100	  ±	   749	  meters	  per	  day	   and	  57.8	  ±	   7.6	   km	   cumulative,	   n=6.	  Animals	   that	  were	  housed	   in	  
running	  wheel	  cages	  for	  7-­‐days	  prior	  to	  removal	  of	  wheels	  for	  a	  3-­‐day	  sedentary	  period	  (7d	  RW	  
+	  3d	  sed.	  group)	  ran	  an	  average	  of	  6788	  ±	  1244	  meters	  per	  day,	  47.5	  ±	  25.7	  km	  cumulative,	  n	  =4.	  
There	  were	  no	  significant	  differences	  between	  the	  daily	  averages	  of	  the	  groups,	  p=0.54,	  or	  the	  
cumulative	   distances,	   p=0.54,	   therefore	   comparison	   between	   groups	   is	   acceptable	   (Ordinary	  
one-­‐way	  ANOVA).	  Distance	  run	  per	  day	  over	  time	  did	  significantly	  increase	  as	  all	  animals	  ran	  an	  
average	  of	  7389	  ±	  2746	  m	  on	  day	  1	  and	  8489	  ±	  2601	  m	  on	  day	  7,	  p<0.01	  (Two-­‐way	  ANOVA).	  




Figure	  3.1	  There	  is	  no	  significant	  variation	  in	  running	  wheel	  distances	  between	  groups.	  
(A)	   There	  was	   no	   significant	   difference	   in	   the	   average	   distance	   run	   per	   day	   between	   any	   of	   the	   groups.	   There	  was	   a	   significant	   interaction	  
between	  distance	  run	  and	  time	  (Two-­‐way	  ANOVA	  **p<0.01)	  where	  animals	  ran	  more	  on	  day	  7	  than	  they	  had	  on	  day	  1.	  (B)	  Cumulative	  running	  
wheel	  distances	  were	  not	  statistically	  different	  between	  groups.	  Data	  points	  represent	  average	  running	  wheel	  distance	  within	  the	  group.	  n=6	  for	  
RW	  +	  MCAo,	  n=4	  for	  7d	  RW	  and	  7d	  RW	  +	  3d	  sed.	  groups.	  Data	  presented	  as	  mean	  ±	  SEM.	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Effect	  of	  7	  days	  of	  Exercise	  on	  Infarct	  Volume	  
Infarct	   volumes	   from	   animals	   in	   the	   7d	   RW	   +	  MCAo	   and	   sedentary	   +	  MCAo	   groups	  were	  
analyzed	   on	   PSD3	   using	   TTC	   staining,	   where	   healthy	   tissue	   stains	   red	   and	   infarcted	   tissue	  
remains	   white	   (Figure	   3.2).	   One	   animal	   in	   each	   group	   displayed	   aspects	   of	   blood	   within	   the	  
infarcted	   region	  consistent	  with	  hemorrhage	  and	  were	  excluded	   from	   the	   study.	  Animals	   that	  
had	  run	  for	  7	  days	  prior	  to	  MCAo	  had	  slightly	  smaller	  infarcts	  than	  those	  in	  the	  sedentary	  control	  
group	  (29.7	  ±	  4.6	  mm3	  vs.	  22.8	  ±	  6.6	  mm3,	  p=0.0895,	  n=5).	  Though	  running	  distances	  between	  
the	   groups	   were	   not	   statistically	   significant	   (Figure	   3.1)	   there	   was	   some	   variation	   within	   the	  
groups.	   Infarct	   volumes	   were	   therefore	   compared	   with	   running	   wheel	   distances	   to	   evaluate	  
potential	   correlations	   (Figure	  3.3).	   There	  was	  no	   correlation	  between	   the	   cumulative	  distance	  
run	  or	  the	  average	  distance	  run	  per	  day	  to	   infarct	  volume	  (Pearson	  correlation=	  -­‐0.048,	  p=0.9,	  
n=5	  for	  both	  tests).	  There	  was,	  however,	  loose	  correlation	  between	  the	  distance	  run	  on	  the	  final	  
day	  of	  exercise	  just	  prior	  to	  MCAo	  and	  infarct	  volume	  though	  this	  was	  not	  statistically	  significant	  
(Pearson	  correlation=	  -­‐.564,	  p=0.32,	  n=5).	  Animals	  ran	  primarily	  during	  the	  dark	  periods	  of	  the	  
animal	   facility	   light	   cycle	   (2100-­‐0700	   local	   time)	  and	   surgeries	  were	  performed	  between	  1000	  
and	  1300	  local	  time;	  therefore	  animals	  were	  occluded	  within	  3	  to	  6	  hours	  of	  running.	  	  We	  next	  
evaluated	  potential	  changes	   in	  protease	  expression	  within	  skeletal	  muscle	  to	   investigate	   if	  any	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Figure	  3.2	  Exercised	  mice	  have	  slightly	  smaller	  infarct	  volumes	  on	  PSD3.	  
(A)	   Animals	   subjected	   to	   MCAo	   after	   7	   days	   of	   housing	   in	   running	   wheel	   cages	   had	   smaller	  
infarct	  volumes	  than	  sedentary	  controls	  on	  PSD3	  (29.7	  ±	  4.6	  mm3	  vs.	  22.8	  ±	  6.6	  mm3)	  though	  the	  
difference	   was	   not	   statistically	   significant	   (p=0.0985,	   Student’s	   t-­‐test,	   n=5).	   (B)	   Representative	  
images	  of	  coronal	  brain	  sections	  from	  sedentary	  and	  exercised	  animals	  used	  for	  infarct	  volume	  
analysis.	  Tissue	  stained	  with	  TTC	  to	  visualize	  infarcted	  areas,	  equation	  2.1	  was	  used	  to	  calculate	  
infarct	  volume.	  White	  arrows	  indicate	  0.0	  bregma	  estimate,	  scale	  bars	  depict	  5	  mm.	  
	  

















































Figure	  3.3	  Infarct	  volumes	  do	  not	  correlate	  significantly	  with	  7	  day	  running	  wheel	  distances.	  
Correlations	  between	  (A)	  cumulative	  distance,	  (B)	  average	  daily	  distance	  and	  (C)	  distance	  on	  day	  
7	  just	  prior	  to	  MCAo	  were	  not	  statistically	  significant.	  Distance	  run	  on	  day	  7	  showed	  the	  highest	  
correlation	   of	   the	   three	   comparisons	   (Pearson	   correlation	   =	   -­‐0.048,	   -­‐0.048	   and	   -­‐0.564	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Protease	  Expression	  after	  7	  days	  of	  Exercise	  
Gastrocnemius	  muscle	  tissue	  from	  all	  groups	  was	  analyzed	  with	  real-­‐time	  PCR	  to	  investigate	  
changes	   in	  the	  expression	  of	  the	  CTSB	  and	  BMP1	  proteases	  previously	  shown	  to	  be	  capable	  of	  
cleaving	   LG3	   from	   the	   full-­‐length	   perlecan	   molecule.	   RNA	   levels	   of	   CTSB	   and	   BMP1	   were	  
compared	  to	   levels	   in	  sedentary,	  naïve	  control	  mice	  using	  RPL38	  as	  an	   internal	  control	   (Figure	  
3.4	   A	   &B).	  CTSB	   levels	   were	   not	   significantly	   different	   in	   any	   of	   the	   groups	   (One-­‐way	   ANOVA,	  
p=0.6425,	   n=4	   for	   naïve	   groups,	   n=5	   for	   MCAo	   groups).	   Protein	   expression	   levels	   of	   pro-­‐	   and	  
mature	  forms	  of	  CTSB	  in	  gastrocnemius	  muscle	  tissue	  were	  analyzed	  using	  Western	  blotting	  to	  
determine	   if	  the	  RNA	  levels	  reflected	  protein	  expression	  (Figure	  3.4.	  C-­‐E).	  No	  differences	  were	  
detected	   between	   the	   naïve	   sedentary	   mice	   or	   exercised	   groups	   (One-­‐way	   ANOVA,	   p=0.09,	  
n=4).	  There	  was	  also	  no	  difference	  in	  CTSB	  between	  the	  MCAo	  groups	  (Student’s	  t-­‐test,	  p=0.48,	  
n=5).	  BMP1	  RNA	  levels,	  however,	  did	  show	  significant	  differences	  among	  groups.	  BMP1	  levels	  in	  
gastrocnemius	   tissue	   from	   mice	   that	   ran	   for	   7	   days	   was	   increased	   1.4	  ±	   0.12-­‐fold	   over	   naïve	  
sedentary	  mice	  (One-­‐way	  ANOVA	  with	  Dunnett’s	  post	  hoc	  analysis	  **p<0.01,	  n=3).	  A	  1.3	  ±	  0.15-­‐
fold	  increase	  over	  sedentary	  controls	  was	  maintained	  after	  a	  3-­‐day	  sedentary	  period	  (One-­‐way	  
ANOVA	   with	   Dunnett’s	   post	   hoc	   test	   *p<0.05,	   n=4).	   BMP1	   was	   not,	   however,	   significantly	  
elevated	  in	  either	  of	  the	  MCAo	  groups.	  BMP1	  in	  the	  sedentary	  +	  MCAo	  was	  very	  similar	  to	  that	  
detected	   in	  the	  naïve	  sedentary	  group.	  The	  7d	  RW	  +	  MCAo	  group	  displayed	  a	  trend	  of	  slightly	  
elevated	   levels	   of	   BMP1	   compared	   to	   control.	   These	   data	   indicate	   that	   running	   itself	   is	  
responsible	   for	   the	   increase	   in	  BMP1	   rather	   than	   the	  physiological	   changes	   that	  arise	  after	  an	  
experimental	   stroke	   injury.	  We	   then	  wanted	   to	  determine	   if	  exercise	  was	   inducing	  changes	   in	  
perlecan	  expression	  and	  to	  also	  assess	  whether	  the	  7-­‐day	  exercise	  paradigm	  used	  in	  the	  current	  
study	  is	  capable	  of	  producing	  a	  change	  in	  muscle	  markers	  of	  exercise	  training.	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Figure	  3.4	  7	  days	  of	  running	  wheel	  significantly	  changes	  expression	  of	  BMP1	  RNA	  but	  does	  not	  




















































































































































































































































































































































































































































p=0.09	   p=0.48	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Figure	   3.4	   cont.	   (A)	   Significant	   differences	   in	   the	   expression	   of	   CTSB	   RNA	   in	   gastrocnemius	  
muscle	   were	   not	   detected	   using	   real-­‐time	   PCR.	   (B)	   BMP1	   RNA	   was	   found	   to	   be	   significantly	  
increased	   in	  naïve	  animals	   that	   ran	   for	  7	  days	  and	  was	  still	  elevated	  after	  a	   subsequent	  3-­‐day	  
sedentary	   period	   (One-­‐way	   ANOVA	   with	   Dunnett’s	   post	   hoc	   test	   **p<0.01,	   *p<0.05,	   n=3,	   n=4	  
respectively).	  Animals	  that	  had	  undergone	  MCAo	  did	  not	  exhibit	  significant	  differences	  in	  BMP1	  
from	  sedentary	  naïve	  controls,	  though	  levels	   in	  the	  7d	  RW	  +	  MCAo	  showed	  an	  elevated	  trend.	  
(C,E)	   Total	   protein	   levels	   of	   CTSB	   were	   not	   significantly	   different	   between	   sedentary,	   7	   day	  
running	   wheel	   or	   7	   day	   running	   wheel	   with	   3-­‐day	   sedentary	   period.	   (D,F)	   There	   was	   also	   no	  
difference	   in	  CTSB	  protein	   levels	  between	  running	  and	  sedentary	  mice	   that	  underwent	  MCAo.	  
(x)	   indicates	   animals	   that	   were	   removed	   from	   study	   due	   to	   hemorrhage.	   RNA	   normalized	   to	  
RPL38	   internal	   control,	   naïve	   sedentary	   group	   used	   to	   calculate	   fold	   change.	   Western	   blots	  
normalized	  to	  GAPDH.	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Perlecan	  and	  PPARGC1A	  RNA	  Expression	  after	  Exercise	  
Analyses	   of	   total	   perlecan	   RNA	   levels	   (HSPG2)	   were	   used	   to	   speculate	   if	   increases	   in	  
perlecan	   expression	   itself	   could	   contribute	   to	   any	   potential	   increases	   in	   LG3	   levels.	   HSPG2	  
expression	  was	  significantly	  upregulated	  after	  7	  days	  of	  exercise	   in	  naïve	  animals	  (1.24	  ±	  0.39-­‐
fold,	  One-­‐way	  ANOVA	  with	  Dunnett’s	  post	  hoc	  test	  **p<0.01,	  n=4)	  (Figure	  3.5	  A).	  This	  increase,	  
however,	  was	   lost	  after	  3	  days	  of	  detraining	  (both	  MCAo	  groups	  had	  running	  wheels	  removed	  
for	   3	   days	   post-­‐surgery	   prior	   to	   tissue	   harvesting).	   As	   a	   master	   regulator	   of	   mitochondria	  
biogenesis	   and	   adaptation	   of	   muscle	   endurance	   in	   response	   to	   exercise	   (Handschin	   &	  
Spiegelman,	   2008;	   Ruas	   et	   al.,	   2012;	   Russell	   et	   al.,	   2003),	  PPARGC1A	   expression	   was	   used	   to	  
measure	   training	   effect.	   There	   was	   only	   a	   slight	   increase	   in	   the	   7-­‐day	   running	   wheel	   group	  
compared	   to	   naïve	   sedentary	   control	   mice	   (1.06	   ±	   0.17-­‐fold),	   all	   other	   groups	   displayed	  
expression	  levels	  slightly	  lower	  than	  control.	  This	  lack	  of	  PPARGC1A	  upregulation	  indicates	  that	  
changes	   in	   transcriptional	   profiles	   indicative	   of	   exercise	   training	   were	   not	   induced	   to	   a	  
significant	   amount	   in	   the	   gastrocnemius	   after	   7	   days	   of	   voluntary	   running.	   Since	   the	   levels	   of	  
BMP1	  and	  HSPG2	  were	  upregulated	  by	  this	  training	  regime,	  we	  next	  wanted	  to	  investigate	  the	  





Figure	   3.5	   HSPG2	   levels	   are	   significantly	   increased	   after	   7	   days	   of	   running	   and	   return	   to	  
baseline	  after	  a	  3-­‐day	  sedentary	  period	  though	  PPARGC1A	  did	  not	  change.	  
HSPG2	  was	   significantly	  upregulated	   in	   the	  7-­‐day	   running	  wheel	  group	   (One-­‐way	  ANOVA	  with	  
Dunnett’s	   post	   hoc	   test,	   **p<0.01,	   n=4).	   Levels	   returned	   to	   baseline	   in	   both	   MCAo	   groups	   as	  
well	   as	   in	   naïve	   mice	   with	   running	   wheels	   removed	   for	   3	   days.	   PPARGC1A	   levels	   were	   not	  
significantly	   different	   between	   any	   of	   the	   sedentary	   or	   running	   wheel	   groups	   (n=4	   in	   naïve	  
groups,	  n=5	  in	  MCAo	  groups)	  signifying	  a	  lack	  of	  training	  effect.	  
	  










































































































Serum	  LG3	  Levels	  
Serum	  collected	  at	  the	  time	  of	  sacrifice	  was	  analyzed	  for	  the	  presence	  of	  LG3	  (Figure	  3.6).	  
Serum	  samples	  from	  all	  groups	  were	  filtered	  through	  50	  kDa	  size	  exclusion	  filters	  to	  reduce	  the	  
interference	   of	   IgG	   light	   chain	   (25	   kDa)	   and	   albumin	   during	   electrophoresis	   and	   detection.	  
Albumin	   has	   been	   shown	   to	   compose	   50%	   to	   60%	   of	   serum	   protein	   and	   is	   not	   completely	  
removed	  by	  filters	  to	  frequently	  produce	  a	  non-­‐specific	  band	  of	  65	  kDa	  (Peters	  Jr,	  1995).	  Purified	  
murine	  LG3	  protein	  was	  run	  alongside	  serum	  samples	  as	  a	  positive	  antibody	  control	  for	  LG3	  (~26	  
kDa).	   A	   band	   corresponding	   to	   the	   molecular	   weight	   of	   LG3	   was	   undetectable	   in	   all	   samples	  
(Figure	  3.6	  A	  &	  C).	  Various	  concentrations	  of	  purified	  murine	  LG3	  were	  mixed	  with	  serum	  and	  
filtered	   as	   additional	   positive	   controls	   on	   separate	   Western	   blots	   where	   a	   light	   band	  
corresponding	   to	   the	   molecular	   weight	   of	   LG3	   was	   detected	   from	   10	   µL	   of	   0.6	   µg/mL	   LG3	  
(estimated	  6	  ng	  total	  LG3	  present	  on	  membrane)	  (◊	  Figure	  3.6	  B).	  LG3	  was	  undetectable	  when	  
analyzed	  at	  a	  concentration	  of	  0.1	  µg/mL	  (1	  ng	  total	  LG3).	  Therefore	  it	  is	  possible	  that	  LG3	  levels	  
are	  less	  than	  0.9	  µg/mL	  and/or	  more	  than	  15	  µL	  total	  serum	  is	  required	  for	  analysis.	  There	  was	  
also	  no	  evidence	  of	  DV	  (~85	  kDa),	  though	  it	  is	  expected	  that	  a	  majority	  of	  DV	  would	  be	  removed	  













	   	   	   	   	   	  
Figure	  3.6	  Serum	  levels	  of	  LG3	  are	  too	  low	  for	  detection	  via	  Western	  blot	  
15	  µL	  of	  total	  serum	  was	  analyzed	  per	  animal	  for	  the	  presence	  of	  LG3.	  (A	  &	  C)	  A	  65	  kDa	  band	  
corresponding	  to	  the	  molecular	  weight	  of	  albumin	  was	  detected	  in	  all	  samples,	  however,	  there	  
was	  no	  band	  detected	  at	  the	  molecular	  weight	  corresponding	  to	  LG3	  in	  any	  study	  samples	  (26	  
kDa).	  120	  ng	  of	  purified	  recombinant	  murine	  LG3	  was	  also	  analyzed	  for	  positive	  antibody	  control	  
(A).	   (B)	   Immunoblot	   detection	   limits	   were	   evaluated	   by	   adding	   recombinant	   murine	   LG3	   to	  
normal	   serum	   prior	   to	   50	   kDa	   size	   exclusion	   filtration.	   A	   faint	   band	   corresponding	   to	   the	  
molecular	  weight	  of	  LG3	  was	  detectable	   in	  10	  µL	  total	  serum	  with	  0.6	  µg/mL	  LG3	  added	  for	  a	  
total	   mass	   of	   6	   ng	   (◊),	   however,	   this	   band	   was	   undetectable	   at	   a	   concentration	   of	   0.1	  µg/mL,	  
total	  mass	  of	  1	  ng.	  




































































































































































































































































































































































Cortical	  RNA	  Expression	  of	  Tight	  Junctions	  and	  Inflammatory	  Markers	  After	  MCAo	  	  
Following	  TTC	  staining	  for	  infarct	  analysis,	  ischemic	  areas	  along	  with	  a	  portion	  of	  the	  cortical	  
penumbra	   region	   were	   analyzed	   for	   changes	   in	   gene	   expression	   between	   the	   exercised	   and	  
sedentary	  mice	  after	  MCAo	  (Figure	  3.7).	  All	  samples	  were	  normalized	  to	  an	  18S	  internal	  control.	  
There	   was	   no	   difference	   in	   occludin	   and	   claudin-­‐5	   RNA	   expression	   between	   exercised	   and	  
sedentary	  control	  animals,	  suggesting	  a	  similar	  status	  of	  BBB	  integrity.	  Markers	  of	  inflammation:	  
MMP9,	   ICAM2,	   and	   VCAM1	   displayed	   increased	   variance	   within	   the	   groups	   compared	   to	  
occludin	   and	   claudin-­‐5	   but	   still	   did	   not	   demonstrate	   statistical	   differences	   in	   the	   infarcted	  
regions	   of	   exercised	   and	   sedentary	   mice.	   Additionally,	   expression	   of	   the	   prototypical	   LG3	  
receptor,	  α5	  integrin,	  was	  also	  unchanged.	  Together	  these	  data	  suggest	  that	  the	  slight	  reduction	  
observed	  in	  infarct	  volume	  cannot	  be	  definitively	  attributed	  to	  an	  exercise	  induced	  reduction	  in	  
BBB	  breakdown	  or	  neuroinflammation.	  The	  lack	  of	  LG3	  receptor	  upregulation	  could	  be	  reflective	  
of	   the	   absence	   of	   neuroprotection	   that	   is	   expected	   to	   be	   produced	   from	   exercise	   through	  
















Figure	  3.7	  There	  is	  no	  difference	  in	  the	  gene	  expression	  of	  tight	  junctions	  or	  inflammatory	  markers	  after	  MCAo	  in	  the	  
cortex	  of	  7d	  RW	  and	  sedentary	  mice.	  
RNA	  from	  ischemic	  and	  peri-­‐infarcted	  cortical	  regions	  was	  analyzed	  for	  changes	  in	  expression	  between	  exercised	  and	  
sedentary	  animals.	  No	  significant	  changes	  were	  detected	  in	  markers	  for	  BBB	  integrity	  or	  neuroinflammation.	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CHAPTER	  4:	  DISCUSSION	  
To	   analyze	   the	   effect	   of	   7	   days	   of	   exercise	  on	   ischemic	   infarct	   volume	  we	  used	   the	  distal	  
transient	  MCAo	  model	   of	   experimental	   stroke.	   Results	   from	   this	   study	   showed	   that	   3-­‐month-­‐
old,	  wild	  type	  male	  C57/BL6	  mice	  caged	   in	  running	  wheel	  cages	  for	  7	  days	  had	  slightly	  smaller	  
ischemic	   infarcts	  after	  60	  minutes	  of	  distal	  MCAo,	  a	  model	   that	  has	  not	  been	  used	  previously	  
with	  exercise	  preconditioning.	  The	  size	  of	  the	  infarct	  did	  not	  correlate	  with	  cumulative	  distance	  
or	  daily	  average	  distance	  of	   running.	  There	  was,	  however,	  a	   correlative	   trend	  between	   infarct	  
size	  and	  distance	  run	  during	  the	  night	  prior	  to	  surgery.	  	  
Many	  previous	  studies	  have	  used	  longer	  periods	  of	  2	  to	  4	  weeks	  of	  running	  and	  many	  have	  
used	  rats	  rather	  than	  mice	  (Y.	  H.	  Ding	  et	  al.,	  2005;	  Liebelt	  et	  al.,	  2010;	  Shamsaei	  et	  al.,	  2015;	  Q.	  
Zhang,	   Zhang,	   Yang,	   Wan,	   &	   Jia,	   2014).	   A	   majority	   of	   these	   studies	   have	   also	   used	   an	  
intraluminal	   filament	   model	   to	   produce	   occlusions	   at	   the	   bifurcation	   of	   the	   middle	   cerebral	  
artery	  and	  anterior	  cerebral	  artery	  from	  the	  internal	  carotid	  artery	  rather	  than	  the	  distal	  model	  
used	   in	   the	   current	   study.	   The	   MCAO	   designation	   is	   used	   to	   differentiate	   the	   medial	   MCA	  
occlusion	  versus	   the	  distal	  MCAo	  model.	   In	   the	  MCAo	  model,	   the	  MCA	   is	  occluded	  at	   the	  M4	  
segment	   distal	   to	   the	  M2,	  M3	   and	   lenticulostriate	   vessels	   that	   perfuse	  major	   portions	   of	   the	  
basal	  ganglia	  and	   insular	  cortex	  (Aronowski	  et	  al.,	  1994).	  Occluding	  the	  MCA	  at	  a	  more	  medial	  
location	  that	  encompasses	  all	  branches	  of	  the	  MCA	  in	  the	  MCAO	  model	  produces	  larger	  infarcts	  
that	  involve	  not	  only	  frontal	  and	  parietal	  cortical	  regions	  but	  also	  subcortical	  regions	  such	  as	  the	  
hippocampus,	   striatum,	   thalamus	   and	  midbrain	   (Macrae,	   2011).	   Since	   the	   infarct	   volumes	  are	  
smaller	  in	  the	  MCAo	  model,	  affecting	  only	  the	  cortex,	  the	  effect	  of	  any	  intervention	  needs	  to	  be	  
quite	   robust	   for	   detection	   in	   a	   study	   with	   a	   small	   number	   of	   animals.	   Power	   analysis	   of	   the	  
current	  study	  indicates	  a	  group	  size	  of	  15	  is	  estimated	  to	  detect	  a	  significant	  difference	  using	  α	  =	  
0.05	  and	  d	  =	  0.80	  for	  20%	  effect	  size	  (Snedecor	  &	  Cochran,	  2017)	  if	  the	  populations	  are	  indeed	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different.	   Increasing	   subject	  numbers	   could	   reveal	  a	   significant	  effect	  of	  7	  days	  of	  exercise	  on	  
infarct	  size,	  however,	  in	  many	  previous	  exercise	  studies	  animal	  numbers	  range	  from	  5	  to	  10	  per	  
group	  with	  a	  difference	  of	  20-­‐30%	  in	  infarct	  volume.	  These	  results	  have	  been	  demonstrated	  in	  
both	  exercised	  rats	  and	  mice,	   though	  this	  was	  using	   the	  MCAO	  model	   (Y.	  H.	  Ding	  et	  al.,	  2005;	  
Endres	  et	  al.,	  2003;	  Hayes	  et	  al.,	  2008;	  Liebelt	  et	  al.,	  2010;	  Q.	  Zhang	  et	  al.,	  2014).	  It	  is	  important	  
to	  note,	  however,	  that	  most	  human	  strokes	  are	  relatively	  small	  in	  size,	  ranging	  from	  4.5-­‐14%	  of	  
hemispheric	   volume	   and	   so	   the	   MCAO	   model	   may	   not	   reflect	   the	   typical	   clinical	   condition	  
(Carmichael,	  2005).	  In	  the	  current	  study,	  the	  pooled	  average	  infarct	  volume	  was	  17.1	  ±	  1.8%	  of	  
the	   ipsilateral	   hemisphere,	   compared	   to	   an	   range	   of	   21%	   to	   45%	   in	   many	   studies	   using	   the	  
MCAO	  model	  (Carmichael,	  2005).	  In	  human	  studies,	  infarcts	  larger	  than	  39%	  of	  the	  hemisphere	  
are	  considered	  malignant	  infarcts	  and	  are	  associated	  with	  mortality	  rates	  up	  to	  80%.	  This	  type	  of	  
stroke	  makes	  up	  10%	  of	  clinical	   stroke	  cases	  and	   there	  are	   few	  effective	   treatments	   for	   these	  
patients	  (Hacke	  et	  al.,	  1996).	  Therein,	  the	  smaller	  cortical	  infarct	  produced	  by	  the	  MCAo	  is	  likely	  
the	  most	  physiologically	  relevant	  model.	  	  
Given	   these	   data,	   increasing	   the	   number	   of	   animals	   in	   the	   current	   study	   could	   enable	  
detection	   of	   a	   statistical	   difference	   from	   7	   days	   of	   running	   on	   infarct	   volume,	   however,	   the	  
robustness	  of	  the	  molecular	  changes	  associated	  with	  this	  difference	  may	  not	  be	  physiologically	  
relevant.	   While	   there	   were	   no	   differences	   in	   inflammatory	   marker	   gene	   expression	   in	   the	  
current	   study,	   others	   have	   shown	   a	   significant	   reduction	   after	   longer	   intervals	   of	   exercise	  
preconditioning.	  Y.	  H.	  Ding	  et	  al.	  (2005)	  showed	  that	  rats	  that	  underwent	  3	  weeks	  of	  treadmill	  
training	   displayed	   reduced	   ICAM-­‐1	   mRNA	   expression	   in	   the	   frontoparietal	   cortex	   that	   was	  
associated	  with	   reduced	   peripheral	   leukocyte	   infiltration	   after	  MCAO	   compared	   to	   sedentary	  
controls.	   This	   reduced	   neuroinflammation	   also	   corresponded	   with	   a	   40%	   reduction	   in	   infarct	  
volume,	   supporting	   the	   hypothesis	   that	   exercise	   preconditioning	   may	   reduce	   damage	   by	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mitigating	   the	   surge	   in	   neuroinflammation	   after	   stroke.	   There	   is	   also	   evidence	   for	   the	  
neuroprotective	   effect	   of	   exercise	   against	   other	   forms	   of	   brain	   injury	   such	   as	   traumatic	   brain	  
injury	   (TBI).	   Four	   weeks	   of	   treadmill	   training	   was	   shown	   to	   both	   reduce	   levels	   of	   the	   pro-­‐
inflammatory	  cytokine	  interleukin	  (IL)	  1β	  (IL-­‐1β)	  as	  well	  as	  increase	  anti-­‐inflammatory	  IL-­‐10	  after	  
TBI	  (B.	  Mota	  et	  al.,	  2012).	  Aerobic	  training	  in	  humans	  has	  been	  shown	  to	  reduce	  levels	  of	  MMP9	  
as	  well	  as	  MMP2	  (Nascimento	  Dda	  et	  al.,	  2015),	  which	  is	  considered	  to	  correlate	  with	  increased	  
BBB	   integrity.	  Not	  only	   is	   exercise	  protective	   in	   the	  healthy	  animals	  used	   in	  most	   studies,	   the	  
effects	  of	  exercise	  are	  also	  beneficial	  in	  animals	  with	  co-­‐morbidities.	  Reduction	  of	  BBB	  integrity	  
has	   been	   demonstrated	   in	   the	   streptozotocin	   induced	   diabetic	   mouse	   model	   and	   correlated	  
with	  decreased	  occludin	  expression	  (Hawkins,	  Lundeen,	  Norwood,	  Brooks,	  &	  Egleton,	  2007).	  In	  
this	   same	  diabetic	  model,	   4	  weeks	  of	   treadmill	   training	  maintained	   claudin-­‐5	   levels	   that	  were	  
reduced	  in	  sedentary	  streptozotocin	  mice	  (de	  Senna	  et	  al.,	  2015).	  These	  findings	  further	  support	  
the	   substantial	   role	  of	   exercise	   in	  preserving	   the	  BBB	  via	   reduction	  of	   ECM	  and	   tight	   junction	  
degradation;	   that	   along	   with	   the	   expression	   of	   proinflammatory	   cytokines,	   are	   markers	   of	  
neuroinflammation.	   Both	   wheel	   running	   and	   treadmill	   training	   have	   been	   shown	   to	   increase	  
angiogenesis,	  therein	  total	  microvasculature,	  that	  could	  not	  only	  enable	  collateral	  blood	  supply	  
to	   the	   peri-­‐infarcted	   regions	   but	   also	   increase	   the	   availability	   of	   neuroprotective	   factors	  
throughout	  the	  brain	  (Dirnagl,	  Becker,	  &	  Meisel,	  2009;	  Swain	  et	  al.,	  2003).	  LG3	  signaling	  could	  
underlay	   some	   of	   these	   effects	   as	   DV,	   and	   therein	   LG3,	   has	   been	   shown	   to	   induce	   VEGF	  
expression	   through	   the	   alpha	   5	   integrin	   receptor	   which	   would	   be	   expected	   to	   increase	  
angiogenesis	   (Clarke	  et	  al.,	  2012).	  However,	   the	  specific	  biological	  processes	  that	  underlay	  the	  
changes	  induced	  by	  exercise	  are	  still	  up	  for	  debate.	  
To	   investigate	   the	   progression	   of	   changes	   induced	   by	   exercise,	   Y.	   H.	   Ding	   et	   al.	   (2005)	  
conducted	  a	   time	  course	   study	   to	   analyze	   the	  expression	  of	   ICAM-­‐1	  and	   the	  proinflammatory	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cytokine	  tumor	  necrosis	   factor	  α	   (TNFα)	  over	  3	  weeks	  of	   treadmill	   training.	   Interestingly,	   they	  
found	  increased	  basal	  levels	  of	  ICAM-­‐1	  and	  TNFα	  in	  the	  brains	  of	  naïve	  mice,	  the	  magnitude	  of	  
which	  coincided	  with	  the	  cumulative	  amount	  of	  exercise	  (Y.	  H.	  Ding	  et	  al.,	  2005).	  These	  changes	  
could	  be	  indicative	  of	   ischemic	  pre-­‐conditioning:	  the	  notion	  that	  applying	  an	  ischemic	  stimulus	  
at	  levels	  below	  the	  threshold	  for	  damage	  can	  augment	  the	  expression	  of	  neuroprotective	  factors	  
to	  be	  kept	  in	  reserve	  for	  a	  supra-­‐threshold	  attack.	  Small	  repetitive	  intervals	  of	  cerebral	  ischemia	  
24	   to	   96	   hours	   prior	   to	  MCAO	   have	   been	   shown	   to	   reduce	   infarct	   volume	   without	   inducing	  
neuronal	  death	  on	  its	  own	  (Shin	  et	  al.,	  2009;	  J.	  Zhang,	  Yang,	  Klaus,	  Koehler,	  &	  Huang,	  2008).	  It	  is	  
possible	   that	   by	   expressing	   slightly	   elevated	   levels	   of	   ICAM-­‐1	   and	   TNFα	   prior	   to	   stroke,	   the	  
protective	  effects	  of	  inflammation	  are	  gained,	  that	  is	  to	  clear	  cellular	  debris	  and	  make	  space	  for	  
regeneration,	  without	   inducing	  a	   chronic,	  degenerative	   inflammatory	  environment.	  Moreover,	  
others	  have	  shown	  that	  inducing	  remote	  ischemic	  preconditioning	  (rIPC)	  at	  sites	  distal	  to	  organs	  
susceptible	   to	   ischemia	   such	   as	   the	   brain	   and	   the	   heart,	   also	   promotes	   protection.	   Inducing	  
remote	   ischemia	   on	   the	   hind	   limb	   by	   surgically	   occluding	   the	   femoral	   artery	   or	   applying	   a	  
tourniquet	  has	  been	  shown	  to	  reduce	  neurological	  deficits	  and	  cerebral	   infarct	  volume	  by	  40%	  
(Hu,	   Lu,	   Zhang,	   Li,	  &	   Jiang,	   2013;	   Ying	   Zhang	   et	   al.,	   2012).	   This	  method	  of	   rIPC	   has	   also	   been	  
mimicked	   in	   humans	   where	   blood	   pressure	   cuffs	   can	   be	   used	   to	   induce	   short	   intervals	   of	  
ischemia	  to	  a	  limb.	  Serum	  from	  these	  individuals	  was	  shown	  to	  reduce	  infarct	  size	  when	  used	  to	  
perfuse	  hearts	  isolated	  from	  experimental	  animals	  in	  an	  ex-­‐vivo	  method	  of	  myocardial	  infarction	  
(Michelsen	  et	  al.,	  2012).	  Additionally,	  similar	  levels	  of	  protection	  were	  achieved	  from	  the	  serum	  
of	  human	  subjects	   that	  had	  undergone	  exercise	   tests	   such	  as	   swimming	  and	  running	   (Jean-­‐St-­‐
Michel	  et	  al.,	  2011).	  The	  buildup	  of	  lactate	  from	  anaerobic	  respiration	  after	  running	  suggests	  an	  
ischemic	  environment	  is	  associated	  with	  exercise	  (Ferreira	  et	  al.,	  2007).	  The	  findings	  from	  these	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studies	   suggest	   that	   exercise	   could	   be	  method	   of	   achieving	   remote	   ischemic	   preconditioning	  
through	  factors	  released	  into	  circulation.	  
There	  are	  numerous	  studies	  that	  have	  demonstrated	  the	  importance	  of	  an	  array	  of	  specific	  
effectors	  of	  exercise	  such	  as	  endothelial	  nitric	  oxide	  synthase	  (Endres	  et	  al.,	  2003)	  and	  BDNF	  (Y.	  
Ding	  et	  al.,	  2004)	   for	  example;	  none-­‐the-­‐less	   the	  search	   for	  a	  universal	  neuroprotective	   factor	  
that	  has	  the	  potential	  for	  clinical	  translation	  has	  continued.	  An	  ideal	  molecule	  would	  encompass	  
the	   capability	   for	   rapid,	   robust	   generation	   upon	   stimulation	   while	   exhibiting	   an	   appropriate	  
spatial	   expression	   pattern.	   An	   extracellular	   matrix	   component	   such	   as	   perlecan	   possesses	  
opportune	  localization	  as	  its	  proximity	  to	  circulation	  as	  well	  as	  the	  surrounding	  tissue	  enables	  bi-­‐
directional	   responses	   and	   actions.	   The	   neuroprotective	   effects	   of	   the	   DV	   and	   LG3	   fragments	  
have	  been	  demonstrated	  in	  several	  stroke	  models	  (Al-­‐Ahmad	  et	  al.,	  2011;	  Bix	  et	  al.,	  2013;	  Lee	  et	  
al.,	   2011).	   There	   is	   also	   evidence	   for	   the	   association	   of	   LG3	   and	   exercise.	   Using	   surface-­‐
enhanced	   laser	  desorption/ionization	   (SELDI)	  mass	  spectrometry,	  Parker	  et	  al.	   (2012)	  was	  able	  
to	  detect	  elevated	  levels	  of	  LG3	  in	  the	  urine	  of	  individuals	  in	  labor-­‐intensive	  mining	  occupations	  
after	   their	   work	   shift.	   Elevated	   LG3	   levels	   were	   specific	   to	   employees	   assigned	   to	   physically	  
demanding	   occupations	   rather	   than	   those	   in	  more	   sedentary,	   support	   positions.	   It	   is	   possible	  
that	   the	   increased	   LG3	   present	   in	   urine	   is	   due	   to	   mechanical	   stress	   on	   blood	   vessels	   during	  
physical	  exertion.	  However,	  the	  increased	  expression	  of	  BMP-­‐1,	  a	  protease	  known	  to	  cleave	  LG3	  
(Gonzalez	  et	  al.,	  2005),	  in	  the	  current	  study	  suggests	  a	  more	  specific	  exercise	  induced	  cleavage.	  
The	  concurrent	  increase	  in	  perlecan	  gene	  expression	  implies	  that	  not	  only	  is	  there	  the	  potential	  
for	  increased	  liberation	  of	  LG3	  by	  BMP-­‐1,	  but	  an	  increased	  availability	  of	  substrate	  as	  well.	  While	  
LG3	   was	   not	   detected	   in	   serum	   in	   the	   current	   study,	   it	   is	   very	   likely	   that	   a	   more	   sensitive	  
technique	   such	   as	   SELDI	   mass	   spectrometry	   would	   be	   able	   to	   detect	   a	   change	   in	   LG3	   in	  
exercised	  mice.	  Serum	  was	  drawn	  approximately	  6	  hours	  after	  the	  end	  of	  the	  dark	  cycle	  when	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running	  wheel	   animals	  were	   typically	  most	   active.	   It	   is	   plausible	   that	   elevated	   LG3	   levels	   are	  
transient	   and	  by	  6-­‐hours	  post	  exercise	   serum	  LG3	  will	   have	   returned	   to	  basal	   levels.	   It	   is	   also	  
probable	   that	   more	   than	   7	   days	   of	   bursts	   of	   LG3	   release	   are	   necessary	   to	   mimic	   the	  
neuroprotection	   demonstrated	   in	   other	   preconditioning	   studies.	   The	   evidence	   of	   LG3	   release	  
with	  exercise	  and	  the	  significant	  neuroprotection	  afforded	  by	  DV/LG3	  post	  MCAo	  suggest	  that	  it	  
is	  a	  viable	  candidate	  as	  a	  molecular	  mediator	  of	  exercise	  neuroprotection	  though	  further	  study	  
is	  required.	  The	  magnitude	  of	  the	  contribution	  of	  LG3	  to	  neuroprotection	  can	  be	  evaluated	  using	  
a	  model	  that	   is	  deficient	  of	  perlecan.	  Knockout	  of	  Hspg2	   induces	  embryonic	   lethality	  at	  E10	  to	  
E12	   predominantly	   due	   to	   defective	   stress	   membrane	   development	   in	   the	   heart	   and	   brain	  
(Arikawa-­‐Hirasawa,	  Watanabe,	  Takami,	  Hassell,	  &	  Yamada,	  1999).	  In	  the	  C1532Yneo	  transgenic	  
mouse,	  a	  neomycin	  cassette	  was	   inserted	   into	  domain	   III	  of	  Hspg2	   (Rodgers,	  Sasaki,	  Aszodi,	  &	  
Jacenko,	   2007).	   These	  mice	   express	   low	   levels	   of	   a	   truncated	   form	   of	   perlecan	   and	   display	   a	  
Schwartz-­‐Jampel	  syndrome-­‐like	  phenotype.	  As	  these	  C1532Yneo	  mice	  express	  reduced	  levels	  of	  
perlecan,	   therein	   LG3,	   it	   would	   be	   predicted	   that	   they	   would	   not	   benefit	   from	   the	  
neuroprotection	   afforded	   by	   LG3	   release	   after	   exercise.	   Furthermore,	   if	   treating	   these	   mice	  
prophylactically	  with	  recombinant	  LG3	  reproduces	  MCAo	  infarct	  reduction	  to	  an	  extent	  similar	  
of	  exercised	  wild	   type	  mice,	   it	   could	   signify	   that	   LG3	   treatment	   can	   replicate	   some	  aspects	  of	  
exercise	  preconditioning.	  	  
The	  effects	  of	  exercise	  on	  stroke	  are	  two-­‐fold.	  Exercise	  ameliorates	  some	  of	  the	  modifiable	  
risk	   factors	   for	   stroke	   and	   also	   affords	   neuroprotection	   itself.	   A	   focus	   on	   the	   vascular	  
contributions	  in	  stroke	  could	  be	  particularly	  insightful	  for	  future	  neurodegenerative	  research	  as	  
increased	  vascular	  resistance	  to	  ischemia	  can	  reduce	  numerous	  degenerative	  processes	  such	  as	  
inflammation,	   edema,	   oxidative	   damage,	   and	   peripheral	   leukocyte	   infiltration	   to	   name	   a	   few.	  
The	   identification	   of	   a	  molecular	  mediator	   of	   physical	   activity	   that	   can	   be	   used	   not	   only	   as	   a	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biomarker	  but	  also	  processes	  broad	  neuroprotective	  effects	  can	  allow	  clinicians	  to	  supplement	  
the	  exercise	  regimes	  of	  patient	  populations	  that	  are	  at	  risk	  of	  stroke,	  especially	  those	  that	  may	  
not	  be	  capable	  of	  achieving	  an	  appropriate	  fitness	  level	  themselves.	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Appendix	  I:	  List	  of	  Abbreviations	  
ACA	   	   Anterior	  Cerebral	  Artery	  
ANOVA	   Analysis	  of	  Variance	  
ATP	   	   Adenosine	  Tri-­‐Phosphate	  
BBB	   	   Blood	  Brain	  Barrier	  
BCA	   	   Bicinchoninic	  Acid	  
BMP-­‐1	  	  	   Bone	  Morphogenic	  Protein	  1	  
BDNF	   	   Brain-­‐Derived	  Neurotrophic	  Factor	  
CBF	   	   Cerebral	  Blood	  Flow	  
CCA	   	   Common	  Carotid	  Artery	  
CDC	   	   Center	  for	  Disease	  Control	  
CLDN5	  	   Claudin-­‐5	  
CO2	   	   Carbon	  Dioxide	  
CTSB	   	   Cathepsin	  B	  
CTSL	   	   Cathepsin	  L	  
DNA	   	   Deoxyribonucleic	  Acid	  
DV	   	   Domain	  V	  (of	  Perlecan)	  
ECM	   	   Extracellular	  Matrix	  
ELVO	   	   Emergent	  Large	  Vessel	  Occlusion	  
ERK	   	   Extracellular	  Signal-­‐Regulated	  Kinase	  
FAM	   	   6-­‐Carboxyfluorescein	  
GAPDH	  	   Glyceraldehyde	  3-­‐Phosphate	  Dehydrogenase	  
HSPG2	  	   Heparin	  Sulfate	  Proteoglycan	  2	  (Perlecan)	  
ICA	   	   Internal	  Carotid	  Artery	  
ICAM	   	   Intracellular	  Adhesion	  Molecule	  
IL-­‐1β	   	   Interleukin-­‐1β	  
IL-­‐10	   	   Interleukin-­‐10	  
ITGA5	   	   Integrin	  Alpha	  5	  
LG3	   	   Laminin-­‐like	  Globular	  Domain	  3	  (of	  Perlecan)	  
MCA	   	   Middle	  Cerebral	  Artery	  
MCAo	   	   Middle	  Cerebral	  Artery	  Occlusion	  
MGB	   	   Minor	  Groove	  Binder	  
MMP	   	   Matrix	  Metalloprotease	  
NGF	   	   Nerve	  Growth	  Factor	  
NHLBI	   	   National	  Heart,	  Lung	  and	  Blood	  Institute	  
NVU	   	   Neurovascular	  Unit	  
OCLN	   	   Occludin	  
PAGE	   	   Polyacrylamide	  Gel	  Electrophoresis	  
PBS	   	   Phosphate	  Buffered	  Saline	  
PCR	   	   Polymerase	  Chain	  Reaction	  
PPARGC1A	   Peroxisome	  Proliferative	  Activated	  Receptor	  Gamma,	  Co-­‐Activator	  1α	  
PSD3	   	   Post	  Stroke	  Day	  3	  
RNA	   	   Ribonucleic	  Acid	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rRNA	   	   Ribosomal	  RNA	  
RIPA	   	   Radioimmunoprecipitation	  Assay	  
rIPC	   	   Remote	  Ischemic	  Preconditioning	  
ROS	   	   Reactive	  Oxygen	  Species	  
RPL38	   	   60S	  Ribosomal	  Protein	  L38	  
RW	   	   Running	  Wheel	  
SDS	   	   Sodium	  Dodecyl	  Sulfate	  
Sed.	   	   Sedentary	  
SELDI	   	   Surface-­‐Enhanced	  Laser	  Desorption/Ionization	  
TBI	   	   Traumatic	  Brain	  Injury	  
TNFα	  	   	   Tumor	  Necrosis	  Factor	  α	  
TTC	   	   2,3-­‐Triphenyltetrazolium	  Chloride	  
VCAM	   	   Vascular	  Cell	  Adhesion	  Molecule	  
VEGF	   	   Vascular	  Endothelial	  Growth	  Factor	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